# Characterization of Hyperpolarized Pyruvate MRI Reproducibility

> **NCT02421380** · NA · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 109 (estimated)

## Conditions studied

- Malignant Solid Tumors

## Interventions

- **DRUG:** Hyperpolarized Pyruvate

## Key facts

- **NCT ID:** NCT02421380
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-04
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 109 (ESTIMATED)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02421380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02421380, "Characterization of Hyperpolarized Pyruvate MRI Reproducibility". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02421380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*